Investigators have recently demonstrated that replenishing the gut microbiome with Akkermansia muciniphila in germ-free mice receiving FMTs from patients responding to immunotherapy promotes CCR9 + CXCR3 + CD4 + T-lymphocyte migration into tumor beds [16]. This evidence concerns the gene CCR9 and neoplasm.